| Title : Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease - Pettigrew_1998_J.Clin.Pharmacol_38_236 |
| Author(s) : Pettigrew LC , Bieber F , Lettieri J , Wermeling DP , Schmitt FA , Tikhtman AJ , Ashford JW , Smith CD , Wekstein DR , Markesbery WR , Orazem J , Ruzicka BB , Mas J , Gulanski B |
| Ref : Journal of Clinical Pharmacology , 38 :236 , 1998 |
| Abstract : |
| PubMedSearch : Pettigrew_1998_J.Clin.Pharmacol_38_236 |
| PubMedID: 98210831 |
| Title : Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group [see comments] [published erratum appears in Neurology 1998 Jul\;51(1):332] - Cummings_1998_Neurology_50_1214 |
| Author(s) : Cummings JL , Cyrus PA , Bieber F , Mas J , Orazem J , Gulanski B |
| Ref : Neurology , 50 :1214 , 1998 |
| Abstract : |
| PubMedSearch : Cummings_1998_Neurology_50_1214 |
| PubMedID: 9595966 |
| Title : Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease [see comments] - Morris_1998_Neurology_50_1222 |
| Author(s) : Morris JC , Cyrus PA , Orazem J , Mas J , Bieber F , Ruzicka BB , Gulanski B |
| Ref : Neurology , 50 :1222 , 1998 |
| Abstract : |
| PubMedSearch : Morris_1998_Neurology_50_1222 |
| PubMedID: 9595967 |